| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |